Skip to content
Search

Latest Stories

PDA writes to GPhC on concerns over apparent failure of pharmacy employers to report coronavirus exposure in workplace

The Pharmacists' Defence Association (PDA) has formally written to the General Pharmaceutical Council (GPhC) over the failure of community pharmacy employers to report any instances of likely exposure to the coronavirus in the workplace.

The PDA has said that it is seriously concerned that there appears to be a failure on the part of pharmacy employers to appropriately report instances of exposure to Covid-19 in the workplace.


In a letter to chief executive of GPhC Duncan Rudkin, PDA said: “This situation will not only impact on the individuals affected and reduce the ability of the sector to learn in preparation for future pandemics, it may also undermine patient and public confidence in the sector and therefore we have now formally raised these concerns with the regulator”.

Whilst employers in other sectors have reported instances of Covid-19 exposure, community pharmacy employers "have collectively failed to report a single instance," PDA director Paul Day mentioned in the letter.

“Confidence in community pharmacy employers properly discharging their duties regarding the health and safety of patients and employees is fundamental.

“The responsibility lies clearly with employers and the absence of any notifications whatsoever for work acquired Covid infections in the community sector must cast significant doubt on compliance with these strict obligations.”

Last month, a survey of PDA members about how the pandemic had been managed by employers included information from 556 respondents that work in community pharmacy.

Of the community pharmacists, 122 said that they had caught Covid-19 and of those, 49 believed that they caught the virus in the workplace.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less